Blood Cell Biomarker May Predict Anthracycline LV Dysfunction

Monitoring of neutrophil-to-lymphocyte ratio could potentially help risk-stratify women on anthracycline chemotherapy for associated left-ventricular dysfunction, a prospective study suggests.
First Look

source https://www.medscape.com/viewarticle/975632?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension